Your session is about to expire
← Back to Search
Control (Submaximal Walkout) for Healthy Subjects
Study Summary
This trial will test whether a walkout at 110% of 1RM can improve back squat performance and exertion levels.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am male.I am between 18 and 45 years old.I have injuries that prevent me from exercising fully.I have had rhabdomyolysis in the past.I have heart or metabolic conditions that limit my ability to exercise.
- Group 1: Control (Submaximal Walkout)
- Group 2: Supramaximal Walkout
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who has the requisite qualifications to participate in this experiment?
"To be considered for this medical trial, patients should not have any pre-existing conditions and must fall within the 18 to 45 age range. Currently, 16 people are being sought after in total."
Is the geriatric population being incorporated into this research?
"This medical trial is recruiting adults aged 18 to 45 years old. Those under the age of 18 have 54 clinical trials they can be considered for, while those over 65 have access to 382 different studies."
What is the aggregate participant count of this medical experiment?
"Indeed, the information hosted on clinicaltrials.gov suggests that this study is still recruiting participants. Initially posted on August 1st 2023 and most recently modified 10 days later, 16 individuals are required from a single medical facility."
Are there any opportunities for prospective participants to join this clinical trial?
"Clinicaltrials.gov reveals that this clinical trial is currently enrolling participants, with the initial post being on August 1st 2023 and the last edit taking place on August 10th 2023."
Share this study with friends
Copy Link
Messenger